198 related articles for article (PubMed ID: 29028284)
1. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
Date K; Ettelaie C; Maraveyas A
J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
[TBL] [Abstract][Full Text] [Related]
2. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
3. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
5. Microparticles and cancer thrombosis in animal models.
Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
[TBL] [Abstract][Full Text] [Related]
6. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
[TBL] [Abstract][Full Text] [Related]
7. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
Kleinjan A; Böing AN; Sturk A; Nieuwland R
Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
[TBL] [Abstract][Full Text] [Related]
8. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
9. Annexin V
Chen Y; Liu J; Su Y; Zhao H; Zhao Y; Wen M; Lu S; Cao X; Zhang W; Liu L; Wu J
Clin Chim Acta; 2022 Nov; 536():169-179. PubMed ID: 36191610
[TBL] [Abstract][Full Text] [Related]
10. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review.
Bucciol R; Othman M
Curr Opin Hematol; 2023 Sep; 30(5):180-185. PubMed ID: 37522480
[TBL] [Abstract][Full Text] [Related]
13. Tumour and microparticle tissue factor expression and cancer thrombosis.
Date K; Hall J; Greenman J; Maraveyas A; Madden LA
Thromb Res; 2013 Feb; 131(2):109-15. PubMed ID: 23237339
[TBL] [Abstract][Full Text] [Related]
14. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
15. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
[TBL] [Abstract][Full Text] [Related]
16. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
17. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
[TBL] [Abstract][Full Text] [Related]
19. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S.
Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P
Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.
Thomas GM; Brill A; Mezouar S; Crescence L; Gallant M; Dubois C; Wagner DD
J Thromb Haemost; 2015 Jul; 13(7):1310-9. PubMed ID: 25955268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]